The experimental findings demonstrated that FMT from all four groups of donors decreased the increasing DAI in mouse colitis, downregulated the levels of inflammatory biomarkers MPO (37, 38) and EPO (39), and regulated homeostasis of colonic inflammatory cytokines and the intestinal barrier. The gene discussed is MPO; the disease is colitis.